Stock listing
Frankfurt:5DT Entera Bio Ltd. Aktie
German listing (Frankfurt) of Entera Bio Ltd. · home listing NASDAQ:ENTX
Follow Entera Bio Ltd. into a list and get an email when it puts out news.
Share price · FWB:5DT
€2.72 EUR +0.24 (+9.7%)
Close on Oct 30, 2026
- Day range
- €2.72 – €2.72 EUROct 30, 2026
- Market cap
- €472.8M EURAt the close on Oct 30, 2026 · price × 173.8M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ENTX · Home | $3.20 USD | +0.08 (+2.6%) | 292,681 | $3.06 | $3.24 | $2.95 | $3.12 | Close on Oct 30, 2026 |
| Frankfurt:5DT | €2.72 EUR | +0.24 (+9.7%) | — | €2.72 | €2.72 | €2.72 | €2.48 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:5DT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 27, 2026
Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors
Calls
Replays
Entera Bio (NASDAQ:ENTX) Q1 2022 Earnings Call
Wed, May 18, 2022 · 8:00 AM ET
Watch TranscriptEntera Bio (NASDAQ:ENTX) Q4 2021 Earnings Call
Tue, Mar 08, 2022 · 8:30 AM ET
Watch TranscriptEntera Bio (NASDAQ:ENTX) Q2 2021 Earnings Call
Mon, Aug 16, 2021 · 8:30 AM ET
Watch Transcript
Latest news
Financings
Private placement of ordinary shares and pre-funded warrants
Aug 7, 2026
Closed: US$275M raised · US$2.04 a share · Leerink Partners +5
Dealers: Leerink Partners (lead), Evercore ISI, Guggenheim Securities, Cantor, LifeSci Capital, Canaccord Genuity
Buyers: BVF Partners L.P. (led the private placement; granted the right to designate two directors); Longitude Capital; Vivo Capital; TCGX; Spruce Street Capital; Venrock Healthcare Capital Partners; RA Capital Management; Perceptive Advisors; Driehaus Capital Management; Logos Capital; Catalio Capital Management
Use of proceeds: Fund EB613 Phase 3 program through NDA submission, advance EB612 into the clinic with OPKO, and extend cash runway into 2030
Decks
Technical Presentation (September 2025)
Technical · 19 slides · September 2025
Technical Presentation (July 2025)
Technical · 14 slides · July 2025
Investor Presentation (March 2023)
Investor deck · 33 slides · March 2023
Investor Presentation (November 2022)
Investor deck · 34 slides · November 2022
Entera Bio Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 32 in the last 12 months · 141 in all · newest Oct 27, 2026 · oldest 2019
- Calls
- 5 calls with a replay · 5 with a transcript · latest May 18, 2022
- Decks
- 9 decks · latest September 2025
Where Entera Bio Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ENTX · Home listing | NASDAQ | United States | USD |
| LS Exchange:A2JQXP | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2JQXP | Lang & Schwarz | Germany | EUR |
| Stuttgart:5DT | Stuttgart | Germany | EUR |
| BOATS:ENTX | BOATS | United States | USD |
| Tradegate:5DT | Tradegate | Germany | EUR |
| Dusseldorf:5DT | Dusseldorf | Germany | EUR |
| Frankfurt:5DT · This page | Frankfurt | Germany | EUR |
| Hamburg:5DT | Hamburg | Germany | EUR |
Log in to ask 6ix AI your own questions about Entera Bio Ltd.